On this Veterans Day we'd like to thank Capt. Jeremy Fresques.
medtechgenie.com/a-veterans-…
Final LCDs for MIGS coverage by four MACs call into question coverage for certain procedures. #reimbursement #glaucoma
medtechgenie.com/final-lcds-…
New data from ASTRO shows SBRT could be highly effective at treating localize kidney cancer. Positive for radiation therapy providers such as @Accuray. #ARAY #radiationtherapy #kidneycancer
medtechgenie.com/sbrt-data-p…
Oxford Nanopore has acquired Norther Nanopore Instruments to boost its solid state nanopore development program which could allow detection of multiple biological molecules such as DNA, RNA, metabolites, and proteins. #sequencing #lifescience #nanopore
medtechgenie.com/oxford-nano…
COMBINEDBrain has started a new study to expedite cures for neurodevelopmental disorders by providing whole genome sequencing (WGS) to infants displaying early symptoms of rare genetic neurodevelopmental disorders. #WGS #sequencing
medtechgenie.com/combinedbra…
Medicare has crosswalked the code for Aspira Womens' Health new OvaWatch test to the old code ensuring continuity of reimbursement. #AWH #ovariancancer
medtechgenie.com/medicare-re…
Helix announces another major health network collaboration on population genomics. #genomics #populationhealth
medtechgenie.com/helix-annou…
New AABB guidelines recommend more restrictive use of blood transfusion. It could impact companies levered to blood testing, collection, and safety. #medtech #AABB #transfusion
medtechgenie.com/new-aabb-gu…
The robots are coming in med-tech! @JNJNews announces the planned commencement of clinical trials on its OTTAVA surgical robot in 2024, potentially increasing competitive concerns for market leader @IntuitiveSurg #JNJ #ISRG #surgicalrobot
medtechgenie.com/the-robots-…
SI-BONE reports strong 3Q23 growth in SI joint fusions and trauma indications for sacral insufficiency fractures with record physician adoption. #SIBN #orthopedics #earnings
medtechgenie.com/si-bone-rep…
Hims & Hers showed continued momentum in the 3Q23 with strong subscriber growth and average revenue per order trends with pending weight loss launch. #HIMS #earnings #telehealth
medtechgenie.com/hims-hers-m…
Medicare has added reimbursement for human exoskeletons with proposed rate of $94,617 effective next year. Creates a $15B reimbursed market and could be a game changer for companies such as @EksoBionics and @ReWalk_Robotics. #EKSO #RWLK #reimbursement
medtechgenie.com/medicare-cr…
Cerus reported a solid 3Q23 and has a number of pending catalysts for its blood product pathogen inactivation technology including U.S. IFC growth and red cell data/approvals over the next 12-18 months. #CERS #earnings #pathogeninactivation
medtechgenie.com/cerus-repor…
@gynesonics raises $67.2 million following a string of positive reimbursement decisions for its uterine fibroid treatment technology. #fibroids #capitalraise #medtech
medtechgenie.com/gynesonics-…
Microbiome wellness company @MyViome acquires Naring Health to provide a more multi-omic patient wellness offering. #microbiome #wellness #acquisitions
medtechgenie.com/microbiome-…
CMS increased reimbursement for @CVRx's Barostim implant procedure for heart failure patients in the HOPPS causing the stock price to jump. #heartfailure #CVRX #reimbursement
medtechgenie.com/increased-b…
Like other dental technology companies, @DentsplySirona faced challenges in the 3Q23 citing declining patient volumes and increased cancellations. #XRAY #dentistry #eanrings
medtechgenie.com/dentsply-si…
A @GEHealthCare study shows AI and imaging may play a roll in finding patients for checkpoint inhibitors where only 15-20% of patients respond. #GEHC #Imaging #immunotherapy
medtechgenie.com/ge-healthca…
Billing AI software leader @Waystar has delayed its IPO citing market conditions; shows challenging environment for healthcare IT companies. #IPO #healthcareIT
medtechgenie.com/billing-sof…
